FDA approves Telix brain cancer imaging drug Pixclara
The US Food and Drug Administration approved Telix Pharmaceuticals New Drug Application for Pixclara to advance imaging procedures in adult and paediatric brain cancer patients
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.